#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Atopic keratoconjunctivitis Nephrotic syndrome Hairy cell leukaemia recurrent Marginal zone lymphoma recurrent Renal disorder Cutaneous T-cell lymphoma Neuroendocrine carcinoma metastatic Systemic lupus erythematosus Small cell lung cancer Osteosarcoma Congenital absence of bile ducts Fallopian tube cancer Squamous cell carcinoma of the oral cavity Acute on chronic liver failure Autoimmune disorder More trials…

    Learn about Rare Diseases

    Cholangitis sclerosing – Treatment Shprintzen-Goldberg syndrome – Treatment Myxofibrosarcoma – Treatment Antisynthetase syndrome – Life with Disease Idiopathic pulmonary fibrosis – Treatment Chordoma – Basic Information Idiopathic pulmonary fibrosis – Basic Information Rhabdoid tumour – Diagnostics Leukoencephalopathy – Treatment Niemann-Pick disease – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    SAR443820 Blu-263 Phosphate Alrefimotide [68GA]GA-NOTA-AE105 Atl001 LUXDEGALUTAMIDE Lutikizumab HALOBETASOL PROPIONATE Siplizumab Rintatolimod Levoleucovorin Vemircopan Izokibep Dantrolene Sodium Efanesoctocog Alfa Paroxetine LY3537021 Selexipag Triamcinolone Calcipotriol More therapies…

    Learn about Your Condition

    Drug eruption T-cell type acute leukaemia Diabetic foot Knee arthroplasty Neurodegenerative disorder Paraganglion neoplasm Diabetes mellitus Still's disease Niemann-Pick disease Lymphocytic leukaemia Gallbladder cancer Mixed dementia Device related infection Vascular malformation Gouty arthritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study to evaluate the safety and effectiveness of empasiprubart and efgartigimod alfa in patients with generalized myasthenia gravis.

    Recruiting

    2 1 1
    Investigated Drugs:
    • Empasiprubart
    • Efgartigimod Alfa
    Belgium Germany Greece Italy The Netherlands Poland +1

  • A study of islatravir and ulonivirine for adults with HIV who have not received previous treatment

    Recruiting

    4 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Islatravir
    • Ulonivirine
    • Emtricitabine
    France Spain

  • A study to evaluate the safety and effectiveness of nucresiran and vutrisiran in patients with hereditary transthyretin amyloidosis with polyneuropathy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Polyneuropathy
    Investigated Drugs:
    • Vutrisiran
    Cyprus France Germany Greece Ireland Italy +3

  • A study of IM-101 in adults with generalized myasthenia gravis or ocular myasthenia gravis

    Recruiting

    1 1 1
    Investigated Drugs:
    • HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE
    • HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA]
    • MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN
    Bulgaria Italy Poland Spain

  • A study of pembrolizumab, cetuximab, and MK-1084 for patients with advanced or metastatic non-small cell lung cancer with KRAS G12C mutations

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • K-ras gene mutation
    • Non-small cell lung cancer
    Investigated Drugs:
    • Pemetrexed Disodium
    • Mk-1084
    • Carboplatin
    Finland Greece Italy The Netherlands Poland Spain

  • A study to evaluate the effects of lutetium (177lu) vipivotide tetraxetan in patients with metastatic hormone sensitive prostate cancer receiving androgen deprivation therapy.

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-dependent prostate cancer
    Investigated Drugs:
    • Lutetium (177Lu) Vipivotide Tetraxetan
    Germany Ireland Spain
Previous Page
1 … 55 56 57 58 59 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!